secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dermata Therapeutics, Inc. (DRMA)
CIK:        0001853816
Form:       8-K
Filed at:   2024-05-17T23:59:59+00:00
Accession:  0001654954-24-006608
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Dermata raises $2.66M via immediate exercise of warrants at reduced price; issues new warrants
--------------------------------------------------------------------------------

- Exercise of 516,336 warrants at reduced exercise price of $5.16 per share for cash gross proceeds of ~$2.66M.
- Issues new Series A warrants for 601,174 shares (exercise price $4.91, 5.5-year term) and Series B warrants for 431,498 shares (exercise price $4.91, 24-month term).
- H.C. Wainwright acts as placement agent; receives 7% cash fee plus 36,144 placement agent warrants at $6.45 exercise price.
- Net proceeds for general corporate purposes including R&D, clinical trials, and working capital.
- Closing expected on or about May 21, 2024; resale registration statement to be filed for new warrant shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1853816/000165495424006608/0001654954-24-006608-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1853816/000165495424006608/drma_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-24-006608

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer